AI assistant
Novonesis AS Director's Dealing 2023
3377_rns_2023-01-27_de59ba64-9eb4-4d57-93ec-d984a2af5451.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
With reference to company announcement no. 2, 2023, Novozymes' Executive Leadership Team has on January 26th, 2023 from Novozymes A/S received the allocated shares from the incentive program for the period 2020-2022. An overview of the number and value of shares allotted is provided below.
January 27, 2023
Company announcement No. 3
Contact information
[email protected]
Tobias Cornelius Björklund
+45 3077 8682
[email protected]
Ludmila Cebanov
+45 3077 0554
[email protected]
Anders Enevoldsen
+45 5350 1453
[email protected]
Novozymes A/S
Krogshøjevej 36
2880 Bagsværd
Denmark
Phone: +45 4446 0000
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 50 00 71 27 LEI-328800T6WNZXD2R3JW3B
Trading by management and close relations of management. Company announcement No. 3
2/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Ester Baiget |
| 2. | Reason for the notification | |
| a) | Position/status | CEO and President |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | |
| a) | Name | Novozymes A/S |
| b) | LEI | 529900T6WNZXD2R3JW38 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | |
| Identification code | Shares | |
| ISIN DK0060336014 | ||
| b) | Nature of the transaction | Shares received as part of incentive program |
| c) | Price(s) and volume(s) | Price(s) Volume(s) |
| DKK 348.30 10,707 shares | ||
| d) | Aggregated information | |
| - Aggregated volume | ||
| - Price | Number of shares: 10,707 | |
| Average price, DKK: 348.30 | ||
| Transaction value, DKK: 3.729.248,10 | ||
| e) | Date of transaction | 2023-01-26 |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 3
3/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Lars Green |
| 2. | Reason for the notification | |
| a) | Position/status | CFO and Executive Vice President |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | |
| a) | Name | Novozymes A/S |
| b) | LEI | 529900T6WNZXD2R3JW38 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | |
| Identification code | Shares | |
| ISIN DK0060336014 | ||
| b) | Nature of the transaction | Shares received as part of incentive program |
| c) | Price(s) and volume(s) | Price(s) Volume(s) |
| DKK 348.30 8,986 shares | ||
| d) | Aggregated information | |
| - Aggregated volume | ||
| - Price | Number of shares: 8,986 | |
| Average price, DKK: 348.30 | ||
| Transaction value, DKK: 3,129,823.80 | ||
| e) | Date of transaction | 2023-01-26 |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 3
4/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Tina Sejersgård Fanø | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Agriculture & Industrial Biosolutions | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | ||
| a) | Name | Novozymes A/S | |
| b) | LEI | 529900T6WNZXD2R3JW38 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares | |
| ISIN DK0060336014 | |||
| b) | Nature of the transaction | Shares received as part of incentive program | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 348.30 | 7,977 shares | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | Number of shares: 7,977 | ||
| Average price, DKK: 348.30 | |||
| Transaction value, DKK: 2,778,389.10 | |||
| e) | Date of transaction | 2023-01-26 | |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 3
5/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Claus Crone Fuglsang |
| 2. | Reason for the notification | |
| a) | Position/status | CSO and Executive Vice President, Research & Development |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | |
| a) | Name | Novozymes A/S |
| b) | LEI | 529900T6WNZXD2R3JW38 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | |
| Identification code | Shares | |
| ISIN DK0060336014 | ||
| b) | Nature of the transaction | Shares received as part of incentive program |
| c) | Price(s) and volume(s) | Price(s) Volume(s) |
| DKK 348.30 4,719 shares | ||
| d) | Aggregated information | |
| - Aggregated volume | ||
| - Price | Number of shares: 4,719 | |
| Average price, DKK: 348.30 | ||
| Transaction value, DKK: 1,643,627.70 | ||
| e) | Date of transaction | 2023-01-26 |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 3
6/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Anders Lund | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Consumer Biosolutions | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | ||
| a) | Name | Novozymes A/S | |
| b) | LEI | 529900T6WNZXD2R3JW38 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | Shares | ||
| ISIN DK0060336014 | |||
| b) | Nature of the transaction | Shares received as part of incentive program | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 348.30 | 7,977 shares | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | Number of shares: 7,977 | ||
| Average price, DKK: 348.30 | |||
| Transaction value, DKK: 2,778,389.10 | |||
| e) | Date of transaction | 2023-01-26 | |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 3
7/7
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Graziela Chaluppe dos Santos Malucelli | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Operations, Supply & Quality | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | ||
| a) | Name | Novozymes A/S | |
| b) | LEI | 529900T6WNZXD2R3JW38 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | Shares | ||
| ISIN DK0060336014 | |||
| b) | Nature of the transaction | Shares received as part of incentive program | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 348.30 | 4,719 shares | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | Number of shares: 4,719 | ||
| Average price, DKK: 348.30 | |||
| Transaction value, DKK: 1,643,627.70 | |||
| e) | Date of transaction | 2023-01-26 | |
| f) | Place of the transaction | Outside a trading venue |
Rethink Tomorrow
novozymes